Differential expression of histone deacetylase and acetyltransferase genes in gastric cancer and their modulation by trichostatin a

Tumor Biology

Volumn 35, Issue 7, 2014, Pages 6373-6381

  Wisnieski, Fernanda ^a   Calcagno, Danielle Queiroz ^a,d   Leal, Mariana Ferreira ^a   Chen, Elizabeth Suchi ^a   Gigek, Carolina Oliveira ^a   Santos, Leonardo Caires ^a   Pontes, Thaís Brilhante ^a   Rasmussen, Lucas Trevizani ^b   Payão, Spencer Luiz Marques ^c   Assumpção, Paulo Pimentel ^d   Lourenço, Laércio Gomes ^a   Demachki, Sâmia ^d   Artigiani, Ricardo ^a   Burbano, Rommel Rodríguez ^d   Cardoso Smith, Marília ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDADE DO SAGRADO CORAÇÃO   (Brazil)

^c FACULDADE DE MEDICINA DE MARÍLIA   (Brazil)

^d FEDERAL UNIVERSITY OF PARÁ   (Brazil)

Author keywords

Acetylation; Gastric cancer; Gene expression; Histone acetyltransferase; Histone deacetylase

Indexed keywords

ACYLTRANSFERASE; HISTONE DEACETYLASE; MESSENGER RNA; TRICHOSTATIN A;

ADULT; ARTICLE; CANCER STAGING; CARCINOGENESIS; CDKN1A GENE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ACTIVITY; DRUG EFFECT; DRUG RESPONSE; EPIGENETICS; FEMALE; GASTRIC CANCER CELL LINE; GCN5 GENE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; HDAC1 GENE; HDAC2 GENE; HDAC3 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NONHUMAN; ONCOGENE MYC; PCAF GENE; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; STOMACH CANCER; TUMOR INVASION;

CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; P300-CBP TRANSCRIPTION FACTORS; RNA, MESSENGER; STOMACH NEOPLASMS; TRANSCRIPTIONAL ACTIVATION;

EID: 84905042374     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-1841-0     Document Type: Article

References (66)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin. 2001;51(1):15-36. (Pubitemid 32166444)
2. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al. Cancer statistics, 2004. CA Cancer J Clin. 2004;54(1):8-29. (Pubitemid 38443417)
3. Russell MC, Mansfield PF. Surgical approaches to gastric cancer. J Surg Oncol. 2013;107(3):250-8.
4. Azad N, Zahnow CA, Rudin CM, Baylin SB. The future of epigenetic therapy in solid tumours-lessons from the past. Nat Rev Clin Oncol. 2013;10(5):256-66.
5. Legube G, Trouche D. Regulating histone acetyltransferases and deacetylases. EMBO Rep. 2003;4(10):944-7. (Pubitemid 37407460)
6. Ropero S, Esteller M. The role of histone deacetylases (HDACs) in human cancer. Mol Oncol. 2007;1(1):19-25. (Pubitemid 46776612)
7. Dangond F, Gullans SR. Differential expression of human histone deacetylase mRNAs in response to immune cell apoptosis induction by trichostatin A and butyrate. Biochem Biophys Res Commun. 1998;247(3):833-7. (Pubitemid 28418477)
8. Marmorstein R. Structure and function of histone acetyltransferases. Cell Mol Life Sci. 2001;58(5-6):693-703. (Pubitemid 32553027)
9. Liby P, Kostrouchova M, Pohludka M, Yilma P, Hrabal P, Sikora J, et al. Elevated and deregulated expression of HDAC3 in human astrocytic glial tumours. Folia Biol (Praha). 2006;52(1-2):21-33. (Pubitemid 44177819)
10. Armas-Pineda C, Arenas-Huertero F, Perezpenia-Diazconti M. Chico-Ponce de Leon F, Sosa-Sainz G, Lezama P, Recillas-Targa F. Expression of PCAF, p300 and Gcn5 and more highly acetylated histone H4 in pediatric tumors. J Exp Clin Cancer Res. 2007;26(2):269-76. (Pubitemid 47025291)
11. Xie HJ, Noh JH, Kim JK, Jung KH, Eun JW, Bae HJ, et al. HDAC1 inactivation induces mitotic defect and caspase-independent autophagic cell death in liver cancer. PLoS ONE. 2012;7(4):e34265.
12. Jung KH, Noh JH, Kim JK, Eun JW, Bae HJ, Xie HJ, et al. HDAC2 overexpression confers oncogenic potential to human lung cancer cells by deregulating expression of apoptosis and cell cycle proteins. J Cell Biochem. 2012;113(6):2167-77.
13. Chen L, Wei T, Si X, Wang Q, Li Y, Leng Y, Deng A, Chen J, Wang G, Zhu S, Kang J. Lysine acetyltransferase GCN5 potentiates the growth of non-small cell lung cancer via promotion of E2F1, Cyclin D1 and Cyclin E1 expression. J Biol Chem. 2013.
14. Choi JH, Kwon HJ, Yoon BI, Kim JH, Han SU, Joo HJ, et al. Expression profile of histone deacetylase 1 in gastric cancer tissues. Jpn J Cancer Res. 2001;92(12):1300-4. (Pubitemid 34036893)
15. Kim JK, Noh JH, Eun JW, Jung KH, Bae HJ, Shen Q, et al. Targeted inactivation of HDAC2 restores p16INK4a activity and exerts antitumor effects on human gastric cancer. Mol Cancer Res. 2013;11(1):62-73.
16. Sakuraba K, Yokomizo K, Shirahata A, Goto T, Saito M, Ishibashi K, et al. TIP60 as a potential marker for the malignancy of gastric cancer. Anticancer Res. 2011;31(1):77-9.
17. Jiang GM, Wang HS, Zhang F, Zhang KS, Liu ZC, Fang R, et al. Histone deacetylase inhibitor induction of epithelial-mesenchymal transitions via up-regulation of Snail facilitates cancer progression. Biochim Biophys Acta. 2013;1833(3):663-71.
18. Liu T, Kuljaca S, Tee A, Marshall GM. Histone deacetylase inhibitors: multifunctional anticancer agents. Cancer Treat Rev. 2006;32(3):157-65.
19. Suzuki T, Yokozaki H, Kuniyasu H, Hayashi K, Naka K, Ono S, et al. Effect of trichostatin A on cell growth and expression of cell cycle- and apoptosis-related molecules in human gastric and oral carcinoma cell lines. Int J Cancer. 2000;88(6):992-7.
20. Wu ZQ, Zhang R, Chao C, Zhang JF, Zhang YQ. Histone deacetylase inhibitor trichostatin A induced caspase-independent apoptosis in human gastric cancer cell. Chin Med J (Engl). 2007;120(23):2112-8. (Pubitemid 350268159)
21. Zou XM, Li YL, Wang H, Cui W, Li XL, Fu SB, et al. Gastric cancer cell lines induced by trichostatin A. World J Gastroenterol. 2008;14(30):4810-5.
22. Zhang X, Yashiro M, Ren J, Hirakawa K. Histone deacetylase inhibitor, trichostatin A, increases the chemosensitivity of anticancer drugs in gastric cancer cell lines. Oncol Rep. 2006;16(3):563-8.
23. Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010;17(12):3077-9.
24. Scholte GH, van Doorn LJ, Quint WG, Lindeman J. Polymerase chain reaction for the detection of Helicobacter pylori in formaldehyde-sublimate fixed, paraffin-embedded gastric biopsies. Diagn Mol Pathol. 1997;6(4):238-43. (Pubitemid 28047561)
25. Leal MF, Nascimento JL M d, da Silva CE, Vita Lamarao MF, Calcagno DQ, Khayat AS, et al. Establishment and conventional cytogenetic characterization of three gastric cancer cell lines. Cancer Genet Cytogenet. 2009;195(1):85-91.
26. Wisnieski F, Calcagno DQ, Leal MF, Dos Santos LC, Gigek Cde O, Chen ES, Pontes TB, Assumpcao PP, de Assumpcao MB, Demachki S, Burbano RR, Smith Mde A. Reference genes for quantitative RT-PCR data in gastric tissues and cell lines. World J Gastroenterol.19 (41):7121-8.
27. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29(9):e45.
28. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods (San Diego). 2001;25(4):402-8. (Pubitemid 34164012)
29. Jin KL, Pak JH, Park JY, Choi WH, Lee JY, Kim JH, et al. Expression profile of histone deacetylases 1, 2 and 3 in ovarian cancer tissues. J Gynecol Oncol. 2008;19(3):185-90.
30. Xu X, Jin H, Liu Y, Liu L, Wu Q, Guo Y, et al. The expression patterns and correlations of claudin-6, methy-CpG binding protein 2, DNA methyltransferase 1, histone deacetylase 1, acetyl-histone H3 and acetyl-histone H4 and their clinicopathological significance in breast invasive ductal carcinomas. Diagn Pathol. 2012;7:33.
31. Niegisch G, Knievel J, Koch A, Hader C, Fischer U, Albers P, Schulz WA. Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers. Urol Oncol. 2012.
32. Song J, Noh JH, Lee JH, Eun JW, Ahn YM, Kim SY, et al. Increased expression of histone deacetylase 2 is found in human gastric cancer. APMIS. 2005;113(4):264-8. (Pubitemid 40676807)
33. Nakagawa M, Oda Y, Eguchi T, Aishima S, Yao T, Hosoi F, et al. Expression profile of class I histone deacetylases in human cancer tissues. Oncol Rep. 2007;18(4):769-74.
34. Mutze K, Langer R, Becker K, Ott K, Novotny A, Luber B, et al. Histone deacetylase (HDAC) 1 and 2 expression and chemotherapy in gastric cancer. Ann Surg Oncol. 2010;17(12):3336-43.
35. Ozdag H, Teschendorff AE, Ahmed AA, Hyland SJ, Blenkiron C, Bobrow L, et al. Differential expression of selected histone modifier genes in human solid cancers. BMC Genomics. 2006;7:90.
36. Santoro F, Botrugno OA, Dal Zuffo R, Pallavicini I, Matthews GM, Cluse L, et al. A dual role for Hdac1: oncosuppressor in tumorigenesis, oncogene in tumor maintenance. Blood. 2013;121(17):3459-68.
37. Stivala LA, Cazzalini O, Prosperi E. The cyclin-dependent kinase inhibitor p21CDKN1A as a target of anti-cancer drugs. Current cancer drug targets.12(2):85-96.
38. Do Nascimento Borges B, Burbano RM, Harada ML. Absence of CIP1/KIP1 hypermethylation in gastric cancer patients from Northern Brazil. In vivo (Athens, Greece).24(4):579-82.
39. Calcagno DQ, Leal MF, Taken SS, Assumpcao PP, Demachki S, Smith Mde A, et al. Aneuploidy of chromosome 8 and C-MYC amplification in individuals from northern Brazil with gastric adenocarcinoma. Anticancer Res. 2005;25(6B):4069-74. (Pubitemid 41665187)
40. Burbano RR, Assumpcao PP, Leal MF, Calcagno DQ, Guimaraes AC, Khayat AS, et al. C-MYC locus amplification as metastasis predictor in intestinal-type gastric adenocarcinomas: CGH study in Brazil. Anticancer Res. 2006;26(4B):2909-14.
41. Assumpcao PP, Ishak G, Chen ES, Takeno SS, Leal MF, Guimaraes AC, et al. Numerical aberrations of chromosome 8 detected by conventional cytogenetics and fluorescence in situ hybridization in individuals from northern Brazil with gastric adenocarcinoma. Cancer Genet Cytogenet. 2006;169(1):45-9. (Pubitemid 44093735)
42. Calcagno DQ, Leal MF, Seabra AD, Khayat AS, Chen ES, Demachki S, et al. de Arruda Cardoso Smith M, Burbano RR. Interrelationship between chromosome 8 aneuploidy, C-MYC amplification and increased expression in individuals from northern Brazil with gastric adenocarcinoma. World J Gastroenterol. 2006;12(38):6207-11. (Pubitemid 44688174)
43. Calcagno DQ, Leal MF, Assumpcao PP, Smith MA, Burbano RR. MYC and gastric adenocarcinoma carcinogenesis. World J Gastroenterol. 2008;14(39):5962-8.
44. Costa Raiol LC, Figueira Silva EC, Mendes da Fonseca D, Leal MF, Guimaraes AC, Calcagno DQ, et al. Interrelationship between MYC gene numerical aberrations and protein expression in individuals from northern Brazil with early gastric adenocarcinoma. Cancer Genet Cytogenet. 2008;181(1):31-5. (Pubitemid 351192032)
45. Calcagno DQ, Guimaraes AC, Leal MF, Seabra AD, Khayat AS, Pontes TB, et al. MYC insertions in diffuse-type gastric adenocarcinoma. Anticancer Res. 2009;29(7):2479-83.
46. Calcagno DQ, Leal MF, Demachki S, Araujo MT, Freitas FW, Oliveira e Souza D, et al. MYC in gastric carcinoma and intestinal metaplasia of young adults. Cancer Genet Cytogenet. 2010;202(1):63-6.
47. Calcagno DQ, Freitas VM, Leal MF, de Souza CR, Demachki S, Montenegro R, Assumpcao PP, Khayat AS, Smith Mde A, dos Santos AK, Burbano RR. MYC, FBXW7 and TP53 copy number variation and expression in gastric cancer. BMC gastroenterology.13:141.
48. Kurland JF, Tansey WP. Myc-mediated transcriptional repression by recruitment of histone deacetylase. Cancer Res. 2008;68(10):3624-9.
49. Knoepfler PS, Zhang XY, Cheng PF, Gafken PR, McMahon SB, Eisenman RN. Myc influences global chromatin structure. EMBO J. 2006;25(12):2723-34. (Pubitemid 43980380)
50. Nagy Z, Tora L. Distinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation. Oncogene. 2007;26(37):5341-57. (Pubitemid 47255920)
51. Kenneth NS, Ramsbottom BA, Gomez-Roman N, Marshall L, Cole PA, White RJ. TRRAP and GCN5 are used by c-Myc to activate RNA polymerase III transcription. Proc Natl Acad Sci U S A. 2007;104(38):14917-22. (Pubitemid 47619568)
52. de Souza CR, Leal MF, Calcagno DQ, Costa Sozinho EK, Borges Bdo N, Montenegro RC, et al. de Arruda Cardoso Smith M, Burbano RR. MYC deregulation in gastric cancer and its clinicopathological implications. PLoS One. 2013;8(5):e64420.
53. Patel JH, Du Y, Ard PG, Phillips C, Carella B, Chen CJ, et al. The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60. Mol Cell Biol. 2004;24(24):10826-34. (Pubitemid 39603138)
54. Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, Vassilev A, et al. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 1998;12(18):2831-41. (Pubitemid 28440142)
55. Liu L, Scolnick DM, Trievel RC, Zhang HB, Marmorstein R, Halazonetis TD, et al. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol Cell Biol. 1999;19(2):1202-9. (Pubitemid 29046862)
56. Sartorelli V, Puri PL, Hamamori Y, Ogryzko V, Chung G, Nakatani Y, et al. Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program. Mol Cell. 1999;4(5):725-34.
57. Schiltz RL, Nakatani Y. The PCAF acetylase complex as a potential tumor suppressor. Biochim Biophys Acta. 2000;1470(2):M37-53. (Pubitemid 30155605)
58. Ying MZ, Wang JJ, Li DW, Yu GZ, Wang X, Pan J, Chen Y, He MX. The p300/CBP associated factor: is frequently downregulated in intestinal-type gastric carcinoma and constitutes a biomarker for clinical outcome. Cancer Biol Ther. 2010;9(4).
59. Tahara E. Genetic pathways of two types of gastric cancer. IARC Sci Publ. 2004;157:327-49.
60. Leal MF, Calcagno DQ. Borges da Costa Jde F, Silva TC, Khayat AS, Chen ES, Assumpcao PP, de Arruda Cardoso Smith M, Burbano RR. MYC, TP53, and chromosome 17 copy-number alterations in multiple gastric cancer cell lines and in their parental primary tumors. J Biomed Biotechnol. 2011;2011:631268.
61. Gray SG, Ekstrom TJ. Effects of cell density and trichostatin A on the expression of HDAC1 and p57Kip2 in Hep 3B cells. Biochem Biophys Res Commun. 1998;245(2):423-7. (Pubitemid 28418517)
62. Glaser KB, Staver MJ, Waring JF, Stender J, Ulrich RG, Davidsen SK. Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines. Mol Cancer Ther. 2003;2(2):151-63.
63. Spiegel S, Milstien S, Grant S. Endogenous modulators and pharmacological inhibitors of histone deacetylases in cancer therapy. Oncogene.31(5):537-51.
64. Senese S, Zaragoza K, Minardi S, Muradore I, Ronzoni S, Passafaro A, et al. Role for histone deacetylase 1 in human tumor cell proliferation. Mol Cell Biol. 2007;27(13):4784-95. (Pubitemid 47016131)
65. Schuettengruber B, Simboeck E, Khier H, Seiser C. Autoregulation of mouse histone deacetylase 1 expression. Mol Cell Biol. 2003;23(19):6993-7004. (Pubitemid 37214666)
66. Gray SG, Ekstrom TJ. The human histone deacetylase family. Exp Cell Res. 2001;262(2):75-83. (Pubitemid 32980246) Tecnológico Nível Superior